Influenza Vaccination in Patients Living With HIV in the Northern Region

Completed

• Conditions: HIV

• Registration Number: NCT04402684
• Lead Sponsor: Tourcoing Hospital

Brief Summary

Anyone living with the Human Immunodeficiency Virus (HIV) has an indication for annual influenza vaccination. (Vaccination schedule and vaccination recommendations 2019). Influenza is a viral infection that has a significant impact on the health care system. However, vaccination coverage in France is still insufficient with regard to the objectives set at 75% by the WHO and the European Commission. For the 2019-2020 seasonal influenza vaccination campaign, flu vaccination by volunteer pharmacists has become possible throughout the country. Studies that have estimated vaccination coverage among HIV-positive populations are rare and show very low rates.

Detailed Description

Cross-sectional study via a self-questionnaire given to all HIV-infected patients coming for a scheduled consultation as part of their HIV follow-up in the spring of 2020. Non-opposition letter given to the patient. Collection of data a posteriori from the medical file recorded in the eNadis patient file.

Study Timeline

• Study Start: 2020-04-10
• Study First Submitted: 2020-04-17
• Study First Submitted QC: 2020-05-20
• Study First Posted: 2020-05-27
• Primary Completion: 2020-09-30
• Study Completion: 2020-12-30
• Status Verified: 2021-01
• Last Update Submitted: 2021-01-25
• Last Update Posted: 2021-01-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 124

Inclusion Criteria

• Any adult person living with HIV presenting for a follow-up consultation in the spring of 2020
• People who do not read French may participate if they wish with the help of a medical or paramedical staff member.
• Patient did not object

Exclusion Criteria

• Minor patients
• Major under guardianship, curatorship, protected person

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
questionnaire influenza vaccine coverage	through study completion, an average of 1 year	The objective of this questionnaire is to estimate the influenza vaccine coverage among PVVIH followed at the Tourcoing Hospital Center.

Secondary Outcome Measures

Name	Time	Method
modalities of influenza vaccination	through study completion, an average of 1 year	To identify the modalities of influenza vaccination when it is carried out
the drivers and disincentives to influenza vaccination	through study completion, an average of 1 year	Estimate from patient reports the drivers and disincentives to influenza vaccination in a specific risk population.

Trial Locations

Locations (1)

CH Tourcoing; 🇫🇷 Tourcoing, France